These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 32163143)

  • 1. Efficacy of radiation boost after breast-conserving surgery for breast cancer with focally positive, tumor-exposed margins.
    Suzuki R; Yoshida M; Oguchi M; Yoshioka Y; Tokumasu K; Osako T; Ono S; Ueno T; Miyagi Y
    J Radiat Res; 2020 May; 61(3):440-446. PubMed ID: 32163143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survival.
    Vos EL; Siesling S; Baaijens MHA; Verhoef C; Jager A; Voogd AC; Koppert LB
    Breast Cancer Res Treat; 2017 Jul; 164(1):157-167. PubMed ID: 28389735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is higher dose radiation necessary for positive resection margin after breast-conserving surgery for breast cancer?
    Cho WK; Choi DH; Park W; Kim H; Cha H
    Breast; 2019 Oct; 47():16-21. PubMed ID: 31265973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.
    Monteau A; Sigal-Zafrani B; Kirova YM; Fourchotte V; Bollet MA; Vincent-Salomon A; Asselain B; Salmon RJ; Fourquet A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1021-8. PubMed ID: 19386441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of boost radiotherapy in early invasive ductal breast cancer with ductal carcinoma in situ component under negative surgical margins.
    Shimizu N; Myojin M; Tamura M; Nishiyama N; Yamashiro K; Yuyama Y; Okazaki Y; Suzuki Y; Takahashi M
    J Radiat Res; 2022 Jan; 63(1):80-87. PubMed ID: 34718690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofractionated radiation therapy for breast ductal carcinoma in situ.
    Hathout L; Hijal T; Théberge V; Fortin B; Vulpe H; Hogue JC; Lambert C; Bahig H; Provencher L; Vavassis P; Yassa M
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1058-63. PubMed ID: 24113057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Radiotherapy Boost for Ductal Carcinoma In Situ With Local Control After Whole-Breast Radiotherapy.
    Moran MS; Zhao Y; Ma S; Kirova Y; Fourquet A; Chen P; Hoffman K; Hunt K; Wong J; Halasz LM; Freedman G; Prosnitz R; Yassa M; Nguyen DHA; Hijal T; Haffty BG; Wai ES; Truong PT
    JAMA Oncol; 2017 Aug; 3(8):1060-1068. PubMed ID: 28358936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
    Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
    Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductal carcinoma in situ--the influence of the radiotherapy boost on local control.
    Wong P; Lambert C; Agnihotram RV; David M; Duclos M; Freeman CR
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e153-8. PubMed ID: 21664063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ.
    Halasz LM; Sreedhara M; Chen YH; Bellon JR; Punglia RS; Wong JS; Harris JR; Brock JE
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e581-6. PubMed ID: 22208975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
    Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
    Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.
    Freedman G; Fowble B; Hanlon A; Nicolaou N; Fein D; Hoffman J; Sigurdson E; Boraas M; Goldstein L
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1005-15. PubMed ID: 10421533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery: a multicenter, retrospective study of 622 patients.
    Cambra MJ; Moreno F; Sanz X; Anglada L; Mollà M; Reyes V; Arenas M; Pedro A; Ballester R; García V; Casals J; Cusidó M; Jimenez C; Escribà JM; Macià M; Solé JM; Arcusa A; Seguí MA; Gonzalez S; Farrús B; Biete A
    Clin Transl Oncol; 2020 May; 22(5):670-680. PubMed ID: 31264148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of Surgical Margin Status in Ductal Carcinoma In Situ.
    Shaikh T; Li T; Murphy CT; Zaorsky NG; Bleicher RJ; Sigurdson ER; Carlson R; Hayes SB; Anderson P
    Clin Breast Cancer; 2016 Aug; 16(4):312-8. PubMed ID: 26952595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial.
    Vrieling C; van Werkhoven E; Maingon P; Poortmans P; Weltens C; Fourquet A; Schinagl D; Oei B; Rodenhuis CC; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan DA; Dubois JB; Remouchamps V; Mirimanoff RO; Hart G; Collette S; Collette L; Bartelink H;
    JAMA Oncol; 2017 Jan; 3(1):42-48. PubMed ID: 27607734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Surgical Margin Following Breast-Conserving Surgery: A Large Population-Based Cohort Study.
    van Deurzen CH
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):627-633. PubMed ID: 27590331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy.
    Rodrigues N; Carter D; Dillon D; Parisot N; Choi DH; Haffty BG
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1331-5. PubMed ID: 12459354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of lumpectomy surface with large field-of-view confocal laser scanning microscope for intraoperative margin assessment - POLARHIS study.
    Sandor MF; Schwalbach B; Hofmann V; Istrate SE; Schuller Z; Ionescu E; Heimann S; Ragazzi M; Lux MP
    Breast; 2022 Dec; 66():118-125. PubMed ID: 36240525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.